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Increase in the Blood Pressure of Rats
Chronically Fed Low Levels of Lead
by H. Mitchell Perry, Jr.,* Margaret W. Erlanger,* and
Elizabeth F. Perry*
Groups of 15 to 18 female weanling Long-Evans rats fed a rye-based diet low in lead (0.25 ppm)
were exposed to 0.1, 1.0, and 5.0 ppm lead in drinldng water. No suggestion of clinical lead toxicity
was recognized. Systolic pressures were measured at 3-month intervals after weaning. The groups of
lead-exposed animals had consistently and significantly higher average pressures than control
animals, the increase approximating 15 mm Hg. With the lowest lead exposure (0.1 ppm), the
increase in average pressure was gradual, being half minimal at 3 months and requiring 1 year to
become maximal. After 1 year, half of these rats had pressures from 0 to 10 mm Hg above the
control average; 40, 20, and 10% had pressures that were 20, 30, and 40 mm Hg, respectively,
above the control average. Thus, rats exposed to lead in amounts comparable to the environmental
exposure of many Americans had an average elevation in systolic pressure comparable to that of
human beings with essential hypertension.
Introduction
Lead has long been blamed for a wide range of toxic
manifestations (1). As early as 1886, high blood lead
was associated with increased risk of high blood
pressure (1). Until recently, the reports of lead intox-
ication have involved heavy exposure, which was
usually occupational in origin. Accurate data on cu-
mulative dose and body burden of lead are difficult to
obtain, but blood lead levels associated with the most
serious chronic toxic manifestations, nephropathy
and encephalopathy, generally range from 100 to 120
gg/dL (2,3) and certainly reflect heavy exposure.
When hypertension has been associated with lead ex-
posure, nephropathy has usually been present, making
it likely that hypertension is of renal origin.
In addition to renal hypertension induced by heavy
lead exposure, it has now been suggested that mild to
moderate hypertension may be associated with long-
term, perhaps lifelong, exposure of a much larger
segment of the population to much lower levels of en-
vironmental lead. Such exposure could result in
widespread but asymptomatic lead toxicity manifested
by the complications of hypertension, particularly
strokes and heart attacks, during middle and later life.
Two independent lines of evidence suggest an asso-
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ciation between low-level lead exposure and some
essential hypertension.
First, long-term exposure of rats to small amounts of
lead in drinking water has induced increased blood
pressure that resembles human essential hypertension
in that there are no obvious associated manifestations,
toxic or otherwise (4-6). The seconfd line of evidence
involves human epidemiologic data, particularly the
recently reported relationships between blood lead and
blood pressure for blood lead levels ranging from 6 to
30 ,ug/dL (7), well below the levels that have previously
been considered toxic. An increase in strokes, myo-
cardial infarction, and total mortality has been re-
ported for blood lead levels in this range (8).
The postulated low-dose lead toxicity manifested by
essential hypertension would be a different phenom-
enon with a different pathogenesis from the previ-
ously described and more familiar high-dose occupa-
tional toxicity manifested by renal hypertension. This
report deals only with the increase in systolic pressure
of rats exposed to low levels oflead. Systolic pressure is
the parameter of choice to follow because, unlike dias-
tolic pressure, it can be repeatedly measured without
injuring the animal. The lead-induced increase in
pressure is reproducible, statistically significant, and
similar to human essential hypertension in generally
being mild to moderate in degree although some
animals have larger increases in pressure.
The data presented here are from two different ex-
periments. In both, groups of rats had increases inPERRY, ERLANGER, AND PERRY
their average systolic pressure of about 15 mm Hg
following exposure to low levels of lead under our
standard, carefully controlled, and low contamination
conditions. The lead exposure ranged from 0.1 to 5.0
ppm dissolved in drinking water. The methodologic
differences between the experiments involved anesthe-
sia (experiment 1) or lack of it (experiment 2) during
measurement of the blood pressure. The results of the
first year of experiment 1 have already been reported
(2) and so are presented here only briefly.
Methods
Weanling female Long-Evans rats were individ-
ually marked, randomly assigned in groups of 14 to 18
animals to stainless-steel cages, and given deionized
water fortified with five essential metals ad libitum.
They were also given a metal-poor, rye-based diet ad li-
bitum that contained 0.25 mg lead and 39 mg calcium
perkg offood and othermetals as described (9). The rats
were maintained under standard low contamination
conditions, including filtered air (10); constant tem-
perature of 210C and relative humidity of 45%; and a
12-hr light-dark cycle. Beyond daily feeding and
watering and weekly cage cleaning, the animals were
not manipulated or disturbed except for periodic
weighings and blood pressure measurements.
Animals were weighed monthly because growth rate
was considered a sensitive index of toxicity. At
intervals of 3 months, indirect systolic pressure in the
tail artery was measured three times in rapid suc-
cession. The median ofthe three pressures was used for
obtaining group averages and for plotting pressure
distributions of individual rats. Pressure measure-
ment was with a Narco Bio-Systems pneumatic
transducer and a Sanborn Recorder, using a modific-
ation of the technique described by Friedman and
Freed (11). The statistical significance ofthe differences
between the average pressure for control and lead-
exposed animals was assessed using Student's t-test.
Two experiments are considered here. The first lasted
18 months and involved 89 control rats and 74 experi-
mental rats that from the time of weaning received
lead, as the acetate, in their fortified drinking water.
There were five groups of experimental animals: one
received water with a final concentration of 0.1 ppm
lead; two received water with 1.0 ppm lead; two received
water with 5.0 ppm lead (Table 1). For the indirect
systolic pressure measurements, the rats were lightly
anesthetized with pentobarbital (0.25 mg/kg body
weight).
The confirmatory experiment lasted 12 months and
involved 69 control and 71 experimental rats that re-
ceived lead as in experiment 1. There were four groups
of experimental animals, two received 0.1 ppm lead and
two received 1.0 ppm lead (Table 1). For this experi-
ment, indirect systolic pressure was measured in con-
scious, unanesthetized rats.
Results
Food and water intake was similar for all groups of
rats in both experiments during the first year of
observation and averaged 6.60 kg of food and 7.05 L of
water per rat. From their food, the control animals
obtained lead which was estimated to total 1.75 mg per
rat during the first year. The lead-exposed animals
had the same intake from food, but they also obtained
lead from water. The 0.1 ppm lead animals ingested 0.71
mg from water during the first year, with the 1.0 and
5.0 ppm animals ingesting 10 and 50 times this
amount, respectively. At the end of the first year, the
animals with the heaviest lead exposure weighed 5%
less than the control animals; the difference was not
statistically significant, and no clinical evidence of
lead toxicity was recognized.
Table 1 cites the average systolic pressure at 3-month
intervals for the control rats that received no lead in
their drinking water and the average increases above
those control values for groups receiving 0.1, 1.0, and
Table 1. Average increase in systolic pressure with chronic low lead exposure.
Increase in systolic pressure, mm Hga
Months ofexposure
Lead exposure, ppm n 3 6 9 12 15 18
Experiment 1, anesthetized ratsb
0 89 103 99 101 102 102 110
0.1 15 5 10* 12 17t 16t 16t
1.0 30 l2+ 13W lit l2t 15t 13t
5.0 29 16+ 15+ 13t 10* 19+ 12
Experiment 2, unanesthetized ratsc
0 69 116 117 118 120
0.1 36 gt 12t 7* 1st
1.0 35 lit 13t lot 14t
aAverage systolic pressure is given for control animals.
bSDvaried from 11 to 14 mm Hg, except at 18 months, when it was 27 mm Hgforthe5.0-ppm group.
CSD was 6 to 7 mm Hg.
*Significant difference from control, p < 0.05.
tSignificant difference from control, p < 0.001.
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Table 2. Distribution of systolic pressure in experiment 2 rats as a function oftime.
Percent ofgroup with systolic pressure in indicated range
Leadintake n < 120 > 120 > 130 > 140 > 150 > 160
Controla 69 65 35 4 0 0 0
0.1ppm 36 13 87 41 19 8 2
3Months 22 78 28 3 0 0
6 Months 14 86 44 16 3 0
12Months 4 96 52 37 22 7
aTime breakdown measurements are not given for control rats because there was little increase over time; only 4% of pressures in control rats.
exceeded 130 mm Hg.
5.0 ppm lead in their drinking water. During the first
year, the average systolic pressure of the anesthetized
control animals (experiment 1) remained essentially
constant at about 100 mm Hg, although there may
have been some increase at 18 months. During the first
year, the average systolic pressure of the unanesthe-
tized control animals (experiment 2) ranged from 116
to 120 mm Hg; this increase over the unanesthetized
control level is what has been regularly observed in the
absence of anesthesia. Pressure-wise, the control group
was very homogeneous, with 80% of the individual
values being from 110 to 130 mm Hg.
Lead-induced increases in pressure appeared within
3 months and persisted for the entire 18 months of
follow-up. The average increases ranged from 5 to 19
mm Hg; three-fourths of the increases were highly
statistically significant (p < 0.001). With the lowest
exposure to lead, the average increase was initially
small and tended to rise during the first year. In con-
trast, with the highest exposure, there was the sug-
gestion of a reverse trend; the full increase was present
at 3 months and tended to become smaller during the
remainder of the first year. Figure 1 shows these
trends during the first year of experiment 1.
In experiment 2, the average systolic pressure of the
0.1 ppm lead group increased successively from 125 to
129 and then to 135 mm Hg at 3, 6, and 12 months,
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FIGURE 1. The change in pressor response (i.e., difference between the
average systolic pressure of control and lead-exposed rats) is given
as a function of time for the lowest and highest lead exposures in
experiment 1. Except for bar marked "NS" (not significant), all
increases were significant with p <0.05.
respectively. Despite this increase in average pressure,
40 to 50% of the lead-exposed animals had systolic
pressures between 120 and 130 mm Hg at all three time
intervals (Table 2). Thus, most of the increase in
average pressure was due to the remaining half of the
rats developing more marked elevations in pressure.
Whereas only 4% of control rats ever had systolic
pressures above 130 mm Hg, 28, 44, and 52% ofthe lead-
exposed rats had pressures above that cut point at 3, 6,
and 12 months, respectively. Moreover, at 12 months,
37, 22, and 7% of the lead-exposed rats had systolic
pressures over 140, 150, and 160 mm Hg (Fig. 2).
Discussion
Low-dose lead exposure is consistently pressor for
rats under the rigid low-contamination conditions
used in our experiments. Exposure to 0.1 ppm lead in
all drinking water provided a weanling rat with 0.04
mg of lead during the first month and with 0.7 mg
during the first year. The standard diet, which all rats
received, contained 2.5 times as much lead as did the
water, but apparently much of the dietary lead was
relatively unavailable.
The average increase in systolic pressure for all lead-
exposed rats approximated 15 mm Hg. In addition, the
distribution of pressures was different for the control
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FIGURE 2. Distribution of all systolic pressures for 69 control rats from
experiment 2 and separate 3-, 6-, and 12-month distributions for 36
minimally lead-exposed (0.1 ppm) from that same experiment.
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rats and those with the lowest lead exposure. The first
two lines of Table 2 indicate a much smaller range of
pressures for the control than for the lead-fed animals.
Eighty percent ofthe former had pressures between 110
and 130 mm Hg versus 50% of the latter, with 40, 20,
and 10% of the latter having pressures greater than 130,
140, and 150 mm Hg. Thus, much of the lead-induced
increase was due to a fraction of the animals with
moderate and marked increases. Moreover, as indi-
cated by the last three lines ofTable 2, the distribution of
pressures for the lead-fed rats differed increasingly
from the distribution for the control rats, which
changed very little with time. Roughly half of the lead-
fed animals continued to have pressures in the 120 to
130 mm Hg range throughout the first year; however,
increasing numbers had values over 130, 140, 150, and
even 160 mm Hg thus producing a stepwise increase
in mean pressure for the group.
Conditions were carefully standardized in these
experiments. Although the standard diet is relatively
low in calcium and contains some lead, it is known to
support normal growth and continuing good health
for the Long-Evans rats used here; moreover, the sys-
tolic pressure of the control animals is reproducible
and well known. Female rats were used because, unlike
males, groups offemales can be housed in a single cage
without fighting. Indirect systolic pressure was used
because it can be repeatedly measured without injur-
ing the animal. In our original experiments, low-dose
pentobarbital anesthesia was used; however, because of
unexpected effects from the anesthetic (12) we have
begun to use trained, conscious rats without anesthe-
tic. Withholding the anesthetic consistently results in
an average increase of almost 20 mm Hg in the systolic
pressure of control rats; however, at the same time, the
standard deviation falls to half of the value observed in
anesthetized rats. Finally, it is worth noting that in
Schroeder's early experiments, using identical rats,
diet, and water, but carried out in a less contaminated
environment with clean filtered rural air and plastic
cages, the control systolic pressures ofanesthetized rats
averaged 85 mm Hg (13).
The mild hypertension without overt toxicity in-
duced by low lead exposure, as described here, would
seem to have a different pathogenesis from the ap-
parently renal hypertension associated with kidney
damage from much higher lead exposure (14). The
hypertension associated with low-dose lead resembles
human essential hypertension in usually being mild,
having no associated abnormalities, and being of
unknown etiology. There has been great variability in
the amount of lead exposure required to induce
hypertension. At one extreme, we found 0.1 ppm to be
pressor. At the other extreme, Victery and co-workers
have found 100 ppm to be pressor (15). These animals
had low renin hypertension and slight increases of
body weight, suggesting that sodium retention might
be responsible forthe hypertension. Thus, doses that are
far higher than our minimum dose may induce the
essential type of hypertension by a mechanism that is
unknown but which does not involve significant
renal dysfunction. This could result from poor bio-
availability of the lead and/or major differences in
dietary constituents, e.g., calcium. This group also
observed increased responsiveness to catecholamines
in lead-exposed rats (16,17).
There are only limited data indicating how much
lead is actually absorbed with different exposures.
Many investigators have used blood lead levels to
estimate lead intake. With chronic exposure, however,
blood lead is a poor measure of body burden. Once
absorbed, lead is slow to leave the body because it has a
major reservoir in bone from which it can only be
leached slowly. The levels of lead in critical tissues
would seem to be better indices of its pharmacologic
effects.
There are suggestive similarities between the lead-
induced essential-type hypertension and the hyper-
tension induced by comparable exposure to cadmium.
The lead and cadmium pressor responses are similar
in magnitude, in causing no overt toxic manifesta-
tions, and in some ofthe associated biochemical effects,
e. g., both lowered tissue concentrations of ATP and
phosphocreatine (18). It is possible that both non-
essential metals compete with some essential metal,
possibly calcium. With our standard experimental
conditions, there is a limited low range of cadmium
concentrations that are pressor (0.1 to 5.0 ppm), with
less than 0.1 ppm having no effect and more than 5.0
ppm beingvasodepressor (10).
Cottier observed the same phenomenon for paren-
teral lead, with repeated SC doses (20 mg lead phos-
phate) being pressor, while half and twice that dose
were not pressor and even may have been depressor in
the case of the higher dose. He also observed that less
than half of the exposed rats had a significant pressor
response to lead (19). The decreasing pressor effectwith
continued relatively high (5.0 ppm) lead exposure
(Fig. 1) suggests that lead too may induce essential-
type hypertension over a limited low range of expo-
sures. In the case of cadmium, there is some evidence
that the pressor response is associated with minimum
sodium retention (20), perhaps enhanced by some
direct vasoconstrictor activity (21). With cadmium-
induced, but not lead-induced, hypertension, we
observed some increase in renin activity (4); however,
others using larger doses of lead have observed
hyporeninemia (16).
Conclusion
Chronic ingestion by rats of small amounts of lead
(0.1 to 5.0 ppm in drinking water) produced an in-
crease in systolic pressure without obvious toxicity.
The increase in pressure averaged about 15 mm Hg,
but this average included some animals with little if
any increase and some with large increases. After 3
months of exposure to the lowest dose (0.1 ppm), only
one-quarter of the animals had even minimum hy-
pertension, but after 1 year of exposure more than half
110HYPERTENSIONINRATS WITHLONG-TERM, LOW-LEVEL LEAD FEEDING 111
were hypertensive and almost one quarter had marked
elevations. This low-exposure, lead-induced hyper-
tension seems to differ from that induced by heavy
occupational exposure to lead that is usually associated
with significant renal dysfunction.
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